{"id":"https://openalex.org/W3203916375","doi":"https://doi.org/10.1182/bloodadvances.2021005566","title":"Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active","display_name":"Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active","publication_year":2021,"publication_date":"2021-10-09","ids":{"openalex":"https://openalex.org/W3203916375","doi":"https://doi.org/10.1182/bloodadvances.2021005566","mag":"3203916375","pmid":"https://pubmed.ncbi.nlm.nih.gov/34614506","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8714724"},"language":"en","primary_location":{"id":"doi:10.1182/bloodadvances.2021005566","doi":"https://doi.org/10.1182/bloodadvances.2021005566","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2021005566","pdf_url":null,"source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1182/bloodadvances.2021005566","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102705548","display_name":"Jacqueline Suen Garcia","orcid":"https://orcid.org/0000-0003-2118-6302","observed_orcids":["https://orcid.org/0000-0003-2118-6302","https://orcid.org/0000-0002-2599-7308"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Jacqueline S. Garcia","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":"https://orcid.org/0000-0003-2118-6302","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045479163","display_name":"Haesook T. Kim","orcid":"https://orcid.org/0000-0003-4889-6849","observed_orcids":["https://orcid.org/0000-0003-4889-6849"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haesook T. Kim","raw_affiliation_strings":["Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; and","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046567640","display_name":"H. Moses Murdock","orcid":"https://orcid.org/0000-0003-4098-8968","observed_orcids":["https://orcid.org/0000-0003-4098-8968"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Moses Murdock","raw_affiliation_strings":["Department of Medicine;"],"raw_orcid":"https://orcid.org/0000-0003-4098-8968","affiliations":[{"raw_affiliation_string":"Department of Medicine;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029278364","display_name":"Corey S. Cutler","orcid":"https://orcid.org/0000-0001-8728-4314","observed_orcids":["https://orcid.org/0000-0001-8728-4314"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Corey S. Cutler","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079853262","display_name":"Jennifer Brock","orcid":"https://orcid.org/0009-0000-9223-1452","observed_orcids":["https://orcid.org/0009-0000-9223-1452"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer Brock","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043391460","display_name":"Mahasweta Gooptu","orcid":"https://orcid.org/0000-0001-8894-2411","observed_orcids":["https://orcid.org/0000-0001-8894-2411"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mahasweta Gooptu","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031812464","display_name":"Vincent T. Ho","orcid":"https://orcid.org/0000-0001-6839-3996","observed_orcids":["https://orcid.org/0000-0001-6839-3996"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vincent T. Ho","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029390145","display_name":"John Koreth","orcid":"https://orcid.org/0000-0002-7428-1330","observed_orcids":["https://orcid.org/0000-0002-7428-1330"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John Koreth","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001407163","display_name":"Sarah Nikiforow","orcid":"https://orcid.org/0009-0001-2711-5575","observed_orcids":["https://orcid.org/0009-0001-2711-5575"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarah Nikiforow","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061484901","display_name":"Rizwan Romee","orcid":"https://orcid.org/0000-0001-9077-4736","observed_orcids":["https://orcid.org/0000-0001-9077-4736"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rizwan Romee","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014845006","display_name":"Roman M. Shapiro","orcid":"https://orcid.org/0000-0002-7622-8322","observed_orcids":["https://orcid.org/0000-0002-7622-8322"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roman Shapiro","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012267461","display_name":"Fiona Loschi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fiona Loschi","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055160574","display_name":"Jeremy\u00a0A. Ryan","orcid":"https://orcid.org/0000-0002-3327-1283","observed_orcids":["https://orcid.org/0000-0002-3327-1283"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeremy Ryan","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":"https://orcid.org/0000-0002-3327-1283","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023833214","display_name":"Geoffrey G. Fell","orcid":"https://orcid.org/0000-0001-6436-6691","observed_orcids":["https://orcid.org/0000-0001-6436-6691"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoffrey Fell","raw_affiliation_strings":["Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Data Science, Dana-Farber Cancer Institute, Boston, MA; and","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104003228","display_name":"Hannah Q. Karp","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hannah Q. Karp","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010935154","display_name":"Fabienne McClanahan Lucas","orcid":"https://orcid.org/0000-0002-4388-0349","observed_orcids":["https://orcid.org/0000-0002-4388-0349"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fabienne Lucas","raw_affiliation_strings":["Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-4388-0349","affiliations":[{"raw_affiliation_string":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026268460","display_name":"Annette S. Kim","orcid":"https://orcid.org/0000-0002-8699-2439","observed_orcids":["https://orcid.org/0000-0002-8699-2439"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Annette S. Kim","raw_affiliation_strings":["Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-8699-2439","affiliations":[{"raw_affiliation_string":"Department of Pathology, Brigham and Women\u2019s Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055416376","display_name":"Danielle M. Potter","orcid":"https://orcid.org/0000-0002-0986-8717","observed_orcids":["https://orcid.org/0000-0002-0986-8717"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Danielle Potter","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036561161","display_name":"Thelma Mashaka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thelma Mashaka","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071023119","display_name":"Richard Maury Stone","orcid":"https://orcid.org/0000-0002-7526-2633","observed_orcids":["https://orcid.org/0000-0002-7526-2633"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard M. Stone","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082924494","display_name":"Daniel J. DeAngelo","orcid":"https://orcid.org/0000-0001-7865-2306","observed_orcids":["https://orcid.org/0000-0001-7865-2306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel J. DeAngelo","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":"https://orcid.org/0000-0001-7865-2306","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022857112","display_name":"Anthony G. Letai","orcid":"https://orcid.org/0000-0002-1993-9013","observed_orcids":["https://orcid.org/0000-0002-1993-9013"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anthony Letai","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079999812","display_name":"Robert Coleman Lindsley","orcid":"https://orcid.org/0000-0001-9822-806X","observed_orcids":["https://orcid.org/0000-0001-9822-806X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Coleman Lindsley","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":"https://orcid.org/0000-0001-9822-806X","affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068050082","display_name":"Robert J. Soiffer","orcid":"https://orcid.org/0000-0002-5810-1192","observed_orcids":["https://orcid.org/0000-0002-5810-1192"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert J. Soiffer","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5054037976","display_name":"Joseph H. Antin","orcid":"https://orcid.org/0000-0003-4627-1714","observed_orcids":["https://orcid.org/0000-0003-4627-1714"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph H. Antin","raw_affiliation_strings":["Department of Medical Oncology, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5102705548"],"corresponding_institution_ids":[],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":{"value":3800,"currency":"USD","value_usd":3800},"fwci":4.385,"has_fulltext":false,"cited_by_count":50,"citation_normalized_percentile":{"value":0.95699518,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"5","issue":"24","first_page":"5536","last_page":"5545"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.8036999702453613,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.8036999702453613,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.18709999322891235,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/venetoclax","display_name":"venetoclax","score":1.0},{"id":"https://openalex.org/keywords/fludarabine","display_name":"fludarabine","score":0.8399999737739563},{"id":"https://openalex.org/keywords/busulfan","display_name":"busulfan","score":1.0},{"id":"https://openalex.org/keywords/reduced-intensity-conditioning","display_name":"reduced-intensity conditioning","score":0.984000027179718},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.8659999966621399},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9110000133514404},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9649999737739563},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9660000205039978},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.9570000171661377},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.8309999704360962},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5130000114440918},{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.8629999756813049}],"concepts":[{"id":"https://openalex.org/C2780611847","wikidata":"https://www.wikidata.org/wiki/Q348922","display_name":"Busulfan","level":4,"score":0.8679163455963135},{"id":"https://openalex.org/C2779675984","wikidata":"https://www.wikidata.org/wiki/Q23671272","display_name":"Venetoclax","level":4,"score":0.8490747213363647},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.8180208206176758},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5932340025901794},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5368645191192627},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44326621294021606},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.3082599639892578},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.30254703760147095},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.29671335220336914},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.16394662857055664},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.1474207639694214},{"id":"https://openalex.org/C2777938653","wikidata":"https://www.wikidata.org/wiki/Q1088156","display_name":"Chronic lymphocytic leukemia","level":3,"score":0.08988979458808899}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002066","descriptor_name":"Busulfan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014184","descriptor_name":"Transplantation, Homologous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014740","descriptor_name":"Vidarabine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019086","descriptor_name":"Bridged Bicyclo Compounds, Heterocyclic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1182/bloodadvances.2021005566","doi":"https://doi.org/10.1182/bloodadvances.2021005566","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2021005566","pdf_url":null,"source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8714724","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8714724","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Adv","raw_type":"Text"},{"id":"pmid:34614506","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34614506","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood advances","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1182/bloodadvances.2021005566","doi":"https://doi.org/10.1182/bloodadvances.2021005566","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2021005566","pdf_url":null,"source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G1653885796","display_name":"Systems Biology of Bone Marrow Failure and MDS for Precision Medicine","funder_award_id":"RC2DK122533","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G5412212939","display_name":"Enhancing Venetoclax Activity in Chemoresistant Acute Myeloid Leukemia","funder_award_id":"K08CA245209","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6950094713","display_name":"Determining the Role of BCOR Mutations in Myeloid Malignancies","funder_award_id":"K08CA204734","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7262171246","display_name":"SPORE in Myeloid Malignancies","funder_award_id":"P50CA206963","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G7844266926","display_name":"Immune Modulation After Allogeneic HCT","funder_award_id":"P01CA229092","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000889887","display_name":"Development of Novel Therapeutic Strategies in Human Leukemias","funder_award_id":"P01CA066996","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1491993932","https://openalex.org/W2029679731","https://openalex.org/W2038795176","https://openalex.org/W2051877520","https://openalex.org/W2059465100","https://openalex.org/W2073140442","https://openalex.org/W2074487662","https://openalex.org/W2083086786","https://openalex.org/W2107027906","https://openalex.org/W2107810465","https://openalex.org/W2129510594","https://openalex.org/W2141368628","https://openalex.org/W2149089431","https://openalex.org/W2154189404","https://openalex.org/W2173773534","https://openalex.org/W2342548326","https://openalex.org/W2379365975","https://openalex.org/W2439825102","https://openalex.org/W2515091391","https://openalex.org/W2517675534","https://openalex.org/W2559537906","https://openalex.org/W2587066646","https://openalex.org/W2783450169","https://openalex.org/W2891092031","https://openalex.org/W2898284215","https://openalex.org/W2917040403","https://openalex.org/W2979469227","https://openalex.org/W2990765700","https://openalex.org/W2995135594","https://openalex.org/W2996264176","https://openalex.org/W2996657019","https://openalex.org/W3013447738","https://openalex.org/W3043154717","https://openalex.org/W3048827006","https://openalex.org/W3081418272","https://openalex.org/W3098856610","https://openalex.org/W3101738346","https://openalex.org/W3115439304","https://openalex.org/W3133628729","https://openalex.org/W3158625116","https://openalex.org/W3164043037"],"related_works":["https://openalex.org/W2152990872","https://openalex.org/W4310103753","https://openalex.org/W3094683180","https://openalex.org/W4417018467","https://openalex.org/W2983857459","https://openalex.org/W4417009852","https://openalex.org/W4417057012","https://openalex.org/W4407976661","https://openalex.org/W4405044479","https://openalex.org/W4389221905"],"abstract_inverted_index":{"Adding":[0],"the":[1,21,31,110],"selective":[2,41],"BCL-2":[3,40],"inhibitor":[4],"venetoclax":[5,68,112,184,228,245],"to":[6,45,101,117,135,171,229],"reduced-intensity":[7],"conditioning":[8],"chemotherapy":[9],"(fludarabine":[10],"and":[11,18,59,89,131,139,156,165,208,225,233],"busulfan":[12,90],"[FluBu2])":[13],"may":[14],"enhance":[15],"antileukemic":[16],"cytotoxicity":[17],"thereby":[19],"reduce":[20],"risk":[22],"of":[23,37,142,173,183,196,241],"posttransplant":[24],"relapse.":[25],"This":[26,251],"phase":[27,33],"1":[28],"study":[29,125,252],"investigated":[30],"recommended":[32],"2":[34],"dose":[35,113],"(RP2D)":[36],"venetoclax,":[38],"a":[39,145,193],"inhibitor,":[42],"when":[43],"added":[44],"FluBu2":[46,230,247],"in":[47,78],"adult":[48],"patients":[49,121,128,220],"with":[50,80,129,221],"high-risk":[51,222],"acute":[52],"myeloid":[53],"leukemia":[54],"(AML),":[55],"myelodysplastic":[56],"syndromes":[57],"(MDS),":[58],"MDS/myeloproliferative":[60],"neoplasms":[61],"(MPN)":[62],"undergoing":[63],"transplant.":[64],"Patients":[65],"received":[66],"dose-escalated":[67],"(200-400":[69],"mg":[70,187],"daily":[71,94,188],"starting":[72],"day":[73,85,99,102,115,118],"-8":[74,116],"for":[75,86,95,189],"6-7":[76],"doses)":[77],"combination":[79],"fludarabine":[81],"30":[82],"mg/m2":[83],"per":[84],"4":[87],"doses":[88,97],"0.8":[91],"mg/kg":[92],"twice":[93],"8":[96],"on":[98,114],"-5":[100],"-2":[103],"(FluBu2).":[104],"Transplant":[105],"related-toxicity":[106],"was":[107,185,205,211,231,253],"evaluated":[108],"from":[109],"first":[111],"28.":[119],"Twenty-two":[120],"were":[122,169,179],"treated.":[123],"At":[124],"entry,":[126],"5":[127],"MDS":[130],"MDS/MPN":[132],"had":[133,144],"5%":[134],"10%":[136],"marrow":[137],"blasts,":[138],"18":[140],"(82%)":[141],"22":[143],"persistent":[146],"detectable":[147],"mutation.":[148],"Grade":[149],"3":[150,161],"adverse":[151],"events":[152],"included":[153],"mucositis,":[154],"diarrhea,":[155],"liver":[157],"transaminitis":[158],"(n":[159],"=":[160],"each).":[162],"Neutrophil/platelet":[163],"recovery":[164],"acute/chronic":[166],"graft-versus-host-disease":[167],"rates":[168],"similar":[170],"those":[172],"standard":[174],"FluBu2.":[175],"No":[176],"dose-limiting":[177],"toxicities":[178],"observed.":[180],"The":[181],"RP2D":[182],"400":[186],"7":[190],"doses.":[191],"With":[192],"median":[194,202],"follow-up":[195],"14.7":[197],"months":[198,213],"(range,":[199],"8.6-24.8":[200],"months),":[201],"overall":[203],"survival":[204,210],"not":[206],"reached,":[207],"progression-free":[209],"12.2":[212],"(95%":[214],"confidence":[215],"interval,":[216],"6.0-not":[217],"estimable).":[218],"In":[219],"AML,":[223],"MDS,":[224],"MDS/MPN,":[226],"adding":[227],"feasible":[232],"safe.":[234],"To":[235],"further":[236],"address":[237],"relapse":[238],"risk,":[239],"assessment":[240],"maintenance":[242],"therapy":[243],"after":[244],"plus":[246],"transplant":[248],"is":[249],"ongoing.":[250],"registered":[254],"at":[255],"clinicaltrials.gov":[256],"as":[257],"#NCT03613532.":[258]},"counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":13},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-10-11T00:00:00"}